A detailed history of Israel Englander (Millennium Management LLC) transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Millennium Management LLC holds 230,379 shares of CNTA stock, worth $3.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
230,379
Previous 49,485 365.55%
Holding current value
$3.89 Million
Previous $446,000 725.78%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.58 - $16.99 $1.55 Million - $3.07 Million
180,894 Added 365.55%
230,379 $3.68 Million
Q2 2024

Aug 14, 2024

SELL
$8.04 - $11.87 $1.91 Million - $2.82 Million
-237,908 Reduced 82.78%
49,485 $446,000
Q1 2024

May 15, 2024

BUY
$6.73 - $12.2 $1.65 Million - $2.99 Million
244,906 Added 576.43%
287,393 $3.25 Million
Q4 2023

Feb 14, 2024

BUY
$5.52 - $8.03 $234,528 - $341,170
42,487 New
42,487 $338,000

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.59B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.